96 followers
RT @RevonSystems: "An Early View of Real-World Patient Response to Sacubitril/Valsartan: A Retrospective Study of Patients with #HeartFailu…
2,971 followers
RT @RevonSystems: "@Novartis has also inked pay-for-performance agreements with @Aetna, @Cigna, @Humana and @HarvardPilgrim, tying the cost…
648 followers
"@Novartis has also inked pay-for-performance agreements with @Aetna, @Cigna, @Humana and @HarvardPilgrim, tying the cost of Entresto to its ability to reduced #heartfailure-related hospitalizations https://t.co/poHl0H5UNT" via @BioPharmaDive. https://t.co
648 followers
"An Early View of Real-World Patient Response to Sacubitril/Valsartan: A Retrospective Study of Patients with #HeartFailure with Reduced Ejection Fraction https://t.co/Cw383FOG8D;" @Novartis & @Humana's Comprehensive Health Insights.
1,218 followers
Study investigates real-world patient response to sacubitril/valsartan https://t.co/ttNzOyN9kb #cardiology #heartfailure https://t.co/rYNB9PmugG
128 followers
The newest addition to my publication list. https://t.co/QJR7Og7cVJ
624 followers
RT @AdisRapidPlus: A recent article published in Advances in Therapy looks at the real world use of Sacubitril/Valsartan. Infographic based…
1,218 followers
A recent article published in Advances in Therapy looks at the real world use of Sacubitril/Valsartan. Infographic based on https://t.co/6UipI8qP1R #patient #heartfailure #RealWorld https://t.co/Inmwg4azvG